US Patent Issued to Fate Therapeutics on Sept. 23 for "Compositions and methods for immune cell modulation in adoptive immunotherapies" (California Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,870, issued on Sept. 23, was assigned to Fate Therapeutics Inc. (San Diego).

"Compositions and methods for immune cell modulation in adoptive immunotherapies" was invented by Jonathan Rosen (San Diego), Betsy Rezner (San Diego), Bahram Valamehr (San Diego), Ryan Bjordahl (San Diego), Eigen Peralta (San Diego) and Ian Hardy (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds that either produced a higher proportion or greater absolute number of phenotypically identified nave, stem cell memory, central memory T cells, adaptive NK cells, and type I NKT cells are identified. Compositions and methods for modulating immune cells including...